Pathological and biochemical investigation of a woman diagnosed with genetic

Creutzfeldt-Jakob disease shortly after parturition
Creutzfeldt-Jakob disease (CJD) is a rare fatal neurodegenerative condition that most commonly occurs in a sporadic form, predominantly in the elderly. Genetic and acquired forms of CJD also occur, and these may affect younger age groups, including women of childbearing age. The transmissible nature of CJD makes horizontal secondary transmission a concern generally; however a foetus born to a mother carrying a pathogenic mutation associated with CJD might be at risk of developing CJD as a result either of genetic inheritance or potential intrauterine exposure to infectivity. Here we report on the pathological investigation of a woman who developed a severe neuropsychiatric illness shortly after giving birth and who was diagnosed with genetic CJD.
Human prion diseases are uniformly fatal neurodegenerative conditions that occur in idiopathic, acquired and genetic forms. All are transmissible, including the genetic forms, of which CJD E200K-129M is the most common [1] . There are analogous diseases in animals, such as scrapie in sheep and the epidemiology of scrapie suggests both horizontal and vertical transmission [2] , but the exact mechanism of maternal transmission in scrapie is a matter of debate, with evidence for in utero exposure in addition to infection via the oral route around the time of birth [3] .
The infectious agent in human and animal prion diseases is thought to be a misfolded and aggregated form of the prion protein (PrP) that undergoes a self-perpetuating conformational transition from the normal cellular isoform (PrP C ) to the disease associated isoform (PrP Sc )
1 that deposits in the brain and, in some prion diseases, at lower levels in peripheral tissues.
The expression of PrP C within a tissue is therefore considered a precondition for both PrP Sc accumulation and prion replication. The presence of PrP C in human blood [4] and human reproductive tissues, notably the placenta, has been documented [5, 6] The patient presented at the age of 32 years, after she gave birth at term with no complications. The baby subsequently showed developmental delay; investigations for a possible underlying metabolic disorder are being undertaken. The first symptoms were somewhat nonspecific comprising anxiety attacks, insomnia, psychotic symptoms and irritability during her pregnancy, which grew worse and resulted in admission to a psychiatric hospital. Before admission to the hospital she had experienced a seizure. Within weeks her state deteriorated: severe insomnia, cognitive decline and progressive gait imbalance was 2 observed; she was unable to communicate properly with the physicians, or to read.
Myoclonic jerks were noted in all extremities. Cranial CT did not reveal atrophy or a spaceoccupying lesion, however, cranial MRI performed one month after her admission revealed symmetric high signal intensity in the caudate nucleus and putamen. EEG showed periodic sharp waves including those with a triphasic morphology. A search for neoplastic disease and Figure 1D ), but not the stripe-like pattern, which is seen frequently, at least in the cohort of Hungarian patients [1] . The internal organs did not show PrP immunostaining. In addition,
there was a lack of depositions of different neurodegenerative disease-related proteins, which often concur with the E200K mutation [1] .
Frozen tissue specimens were available from the brain, spleen, heart, skeletal muscle, liver, lung, kidney, uterus and ovary. Western blot analysis for protease-resistant (disease associated) prion protein (PrP res ) showed readily detectable PrP res in the cerebral cortex (frontal lobe) and in the cerebellum (Figure 2A,B) . The electrophoretic mobility of the non- 129M [1, 8] . Sodium phosphotungstic acid (NaPTA) precipitation in advance of Western blotting was used to enrich for PrP Sc from larger volumes of tissue homogenates of peripheral tissues from this case to determine whether PrP res is present at levels lower than those found in the brain. Recovery of brain PrP res from this case spiked into non-CJD brain and non-CJD spleen homogenate was found to be efficient and functions as a positive control for NaPTA precipitation and Western blotting. However, no specific signal denoting the presence of PrP res was observed in samples of heart, skeletal muscle, spleen, liver, lung, kidney, uterus or ovary from this case ( Figure 2C,D) suggesting that if PrP Sc (and by implication prion infectivity) is present in these tissues it must be present only at very low levels.
To our knowledge this report constitutes the first detailed pathological investigation of a patient with genetic CJD who developed severe neuropsychiatric symptoms shortly after the birth of a child. All of the available clinical, genetic, pathological and biochemical data indicate that this patient had CJD typical of that associated with the E200K-129M haplotype [1] . The absence of detectable PrP res in peripheral tissues is consistent with pathological changes originating in the brain with only limited centrifugal spread to the periphery (as is found in sporadic CJD), compared to variant CJD in which there is clear evidence of peripheral nervous and lymphoreticular tissue involvement [9, 10] . The situation pertaining to ovary and uterus bear further comment: PrP res has been demonstrated in uterus and ovary in a patient with variant CJD who was not pregnant whilst ill [11] , whereas no evidence could be found of the presence of PrP res in the uterus, placenta or amniotic fluid from a gravida with sporadic CJD of the VV1 subtype [12] . Taken together these data and ours indicate that in genetic CJD (of at least the E200K type) the involvement of the female reproductive tract more closely resembles that of sporadic rather than variant CJD. Although this may offer the foetus a degree of protection from intrauterine exposure, it does not obviate the genetic risk.
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Figure legends respectively, prior to NaPTA precipitation, proteinase K digestion and Western blot analysis.
Lanes marked above the figure show analysis of samples from the case in question, whereas those marked below show the analysis of reference standards. Figure 1 11 Figure 2 
